NSAID Prostate Cancer Benefits Greatest In Older Men – Mayo Clinic Study
This article was originally published in The Tan Sheet
Daily nonsteroidal anti-inflammatory drug (NSAID) use resulted in an 83% reduced risk of prostate cancer in white men ages 70 to 79, a study in the March Mayo Clinic Proceedings found
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC